APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drospirenone and Ethinylestradiol Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drospirenone and Ethinylestradiol Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025191 pages

Choose your research edition.

Industry ResearchDrospirenone and Ethinylestradiol Tablets Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Drospirenone and Ethinylestradiol Tablets Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Drospirenone and Ethinylestradiol Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drospirenone and Ethinylestradiol Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Drospirenone and Ethinylestradiol Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Drospirenone and Ethinylestradiol Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drospirenone and Ethinylestradiol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drospirenone and Ethinylestradiol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drospirenone and Ethinylestradiol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drospirenone and Ethinylestradiol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drospirenone and Ethinylestradiol Tablets include Aurobindo Pharma, Barr Pharmaceuticals, Inc., Bayer Weimar GmbH und Co. KG, Camber Pharmaceuticals, Glenmark Pharmaceuticals, Hetero Drugs, MYLAN LABS LTD., Teva Generics and Wellona Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drospirenone and Ethinylestradiol Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drospirenone and Ethinylestradiol Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drospirenone and Ethinylestradiol Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drospirenone and Ethinylestradiol Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Drospirenone and Ethinylestradiol Tablets Segment by Company

Aurobindo Pharma

Barr Pharmaceuticals, Inc.

Bayer Weimar GmbH und Co. KG

Camber Pharmaceuticals

Glenmark Pharmaceuticals

Hetero Drugs

MYLAN LABS LTD.

Teva Generics

Wellona Pharma

Xiromed

Drospirenone and Ethinylestradiol Tablets Segment by Type

With 30 μg Ethinylestradiol

With 20 μg Ethinylestradiol

Drospirenone and Ethinylestradiol Tablets Segment by Application

Moderate Acne

Dysmenorrhea

Premenstrual Syndrome (PMS)

Premenstrual Dysphoric Disorder (PMDD)

Birth Control

Drospirenone and Ethinylestradiol Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drospirenone and Ethinylestradiol Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drospirenone and Ethinylestradiol Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drospirenone and Ethinylestradiol Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drospirenone and Ethinylestradiol Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drospirenone and Ethinylestradiol Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drospirenone and Ethinylestradiol Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drospirenone and Ethinylestradiol Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drospirenone and Ethinylestradiol Tablets Industry Trends Table 2. Drospirenone and Ethinylestradiol Tablets Industry Drivers Table 3. Drospirenone and Ethinylestradiol Tablets Industry Opportunities and Challenges Table 4. Drospirenone and Ethinylestradiol Tablets Industry Restraints Table 5. Global Drospirenone and Ethinylestradiol Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drospirenone and Ethinylestradiol Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Manufacturers Table 9. Global Drospirenone and Ethinylestradiol Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Drospirenone and Ethinylestradiol Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drospirenone and Ethinylestradiol Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drospirenone and Ethinylestradiol Tablets Manufacturers, Product Type & Application Table 13. Global Drospirenone and Ethinylestradiol Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drospirenone and Ethinylestradiol Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of With 30 μg Ethinylestradiol Table 17. Major Manufacturers of With 20 μg Ethinylestradiol Table 18. Global Drospirenone and Ethinylestradiol Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Drospirenone and Ethinylestradiol Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Drospirenone and Ethinylestradiol Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2021-2026) Table 22. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2027-2032) Table 23. Global Drospirenone and Ethinylestradiol Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Moderate Acne Table 29. Major Manufacturers of Dysmenorrhea Table 30. Major Manufacturers of Premenstrual Syndrome (PMS) Table 31. Major Manufacturers of Premenstrual Dysphoric Disorder (PMDD) Table 32. Major Manufacturers of Birth Control Table 33. Global Drospirenone and Ethinylestradiol Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Drospirenone and Ethinylestradiol Tablets Sales by Application (2021-2026) & (K Units) Table 35. Global Drospirenone and Ethinylestradiol Tablets Sales by Application (2027-2032) & (K Units) Table 36. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2021-2026) Table 37. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2027-2032) Table 38. Global Drospirenone and Ethinylestradiol Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2021-2026) & (K Units) Table 40. Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2027-2032) & (K Units) Table 41. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application (2021-2026) Table 42. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application (2027-2032) Table 43. Global Drospirenone and Ethinylestradiol Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Drospirenone and Ethinylestradiol Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Region (2021-2026) Table 46. Global Drospirenone and Ethinylestradiol Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Drospirenone and Ethinylestradiol Tablets Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Drospirenone and Ethinylestradiol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Drospirenone and Ethinylestradiol Tablets Sales by Country (2021-2026) & (K Units) Table 50. North America Drospirenone and Ethinylestradiol Tablets Sales by Country (2027-2032) & (K Units) Table 51. Europe Drospirenone and Ethinylestradiol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Drospirenone and Ethinylestradiol Tablets Sales by Country (2021-2026) & (K Units) Table 53. Europe Drospirenone and Ethinylestradiol Tablets Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Drospirenone and Ethinylestradiol Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Region (2021-2026) Table 64. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Region (2027-2032) Table 65. Aurobindo Pharma Company Information Table 66. Aurobindo Pharma Business Overview Table 67. Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 69. Aurobindo Pharma Recent Development Table 70. Barr Pharmaceuticals, Inc. Company Information Table 71. Barr Pharmaceuticals, Inc. Business Overview Table 72. Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 74. Barr Pharmaceuticals, Inc. Recent Development Table 75. Bayer Weimar GmbH und Co. KG Company Information Table 76. Bayer Weimar GmbH und Co. KG Business Overview Table 77. Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 79. Bayer Weimar GmbH und Co. KG Recent Development Table 80. Camber Pharmaceuticals Company Information Table 81. Camber Pharmaceuticals Business Overview Table 82. Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 84. Camber Pharmaceuticals Recent Development Table 85. Glenmark Pharmaceuticals Company Information Table 86. Glenmark Pharmaceuticals Business Overview Table 87. Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 89. Glenmark Pharmaceuticals Recent Development Table 90. Hetero Drugs Company Information Table 91. Hetero Drugs Business Overview Table 92. Hetero Drugs Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Hetero Drugs Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 94. Hetero Drugs Recent Development Table 95. MYLAN LABS LTD. Company Information Table 96. MYLAN LABS LTD. Business Overview Table 97. MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 99. MYLAN LABS LTD. Recent Development Table 100. Teva Generics Company Information Table 101. Teva Generics Business Overview Table 102. Teva Generics Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Teva Generics Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 104. Teva Generics Recent Development Table 105. Wellona Pharma Company Information Table 106. Wellona Pharma Business Overview Table 107. Wellona Pharma Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Wellona Pharma Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 109. Wellona Pharma Recent Development Table 110. Xiromed Company Information Table 111. Xiromed Business Overview Table 112. Xiromed Drospirenone and Ethinylestradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Xiromed Drospirenone and Ethinylestradiol Tablets Product Portfolio Table 114. Xiromed Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Drospirenone and Ethinylestradiol Tablets Distributors List Table 118. Drospirenone and Ethinylestradiol Tablets Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Drospirenone and Ethinylestradiol Tablets Product Image Figure 2. Global Drospirenone and Ethinylestradiol Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drospirenone and Ethinylestradiol Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Drospirenone and Ethinylestradiol Tablets Sales (2021-2032) & (K Units) Figure 5. Global Drospirenone and Ethinylestradiol Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drospirenone and Ethinylestradiol Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. With 30 μg Ethinylestradiol Image Figure 9. With 20 μg Ethinylestradiol Image Figure 10. Global Drospirenone and Ethinylestradiol Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type (2021-2032) Figure 16. Moderate Acne Image Figure 17. Dysmenorrhea Image Figure 18. Premenstrual Syndrome (PMS) Image Figure 19. Premenstrual Dysphoric Disorder (PMDD) Image Figure 20. Birth Control Image Figure 21. Global Drospirenone and Ethinylestradiol Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2021-2032) Figure 24. Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application (2021-2032) Figure 27. North America Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2021-2032) Figure 29. U.S. Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2021-2032) Figure 34. Germany Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2021-2032) Figure 41. China Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2021-2032) Figure 49. Brazil Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Drospirenone and Ethinylestradiol Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Drospirenone and Ethinylestradiol Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Drospirenone and Ethinylestradiol Tablets Revenue (2021-2032) & (US$ Million) Figure 60. North America Drospirenone and Ethinylestradiol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Drospirenone and Ethinylestradiol Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Europe Drospirenone and Ethinylestradiol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Drospirenone and Ethinylestradiol Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Drospirenone and Ethinylestradiol Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • With 30 μg Ethinylestradiol
  • With 20 μg Ethinylestradiol
Applications
  • Moderate Acne
  • Dysmenorrhea
  • Premenstrual Syndrome (PMS)
  • Premenstrual Dysphoric Disorder (PMDD)
  • Birth Control
Companies covered
  • Aurobindo Pharma
  • Barr Pharmaceuticals, Inc.
  • Bayer Weimar GmbH und Co. KG
  • Camber Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Hetero Drugs
  • MYLAN LABS LTD.
  • Teva Generics
  • Wellona Pharma
  • Xiromed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drospirenone and Ethinylestradiol Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drospirenone and Ethinylestradiol Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drospirenone and Ethinylestradiol Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drospirenone and Ethinylestradiol Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drospirenone and Ethinylestradiol Tablets Market Dynamics
  1. 2.1 Drospirenone and Ethinylestradiol Tablets Industry Trends
  2. 2.2 Drospirenone and Ethinylestradiol Tablets Industry Drivers
  3. 2.3 Drospirenone and Ethinylestradiol Tablets Industry Opportunities and Challenges
  4. 2.4 Drospirenone and Ethinylestradiol Tablets Industry Restraints
3 Drospirenone and Ethinylestradiol Tablets Market by Manufacturers
  1. 3.1 Global Drospirenone and Ethinylestradiol Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drospirenone and Ethinylestradiol Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drospirenone and Ethinylestradiol Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drospirenone and Ethinylestradiol Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drospirenone and Ethinylestradiol Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drospirenone and Ethinylestradiol Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Drospirenone and Ethinylestradiol Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drospirenone and Ethinylestradiol Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drospirenone and Ethinylestradiol Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drospirenone and Ethinylestradiol Tablets Tier 1, Tier 2, and Tier 3
4 Drospirenone and Ethinylestradiol Tablets Market by Type
  1. 4.1 Drospirenone and Ethinylestradiol Tablets Type Introduction
  2. 4.1.1 With 30 μg Ethinylestradiol
  3. 4.1.2 With 20 μg Ethinylestradiol
  4. 4.2 Global Drospirenone and Ethinylestradiol Tablets Sales by Type
  5. 4.2.1 Global Drospirenone and Ethinylestradiol Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Drospirenone and Ethinylestradiol Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Drospirenone and Ethinylestradiol Tablets Revenue by Type
  9. 4.3.1 Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type (2021-2032)
5 Drospirenone and Ethinylestradiol Tablets Market by Application
  1. 5.1 Drospirenone and Ethinylestradiol Tablets Application Introduction
  2. 5.1.1 Moderate Acne
  3. 5.1.2 Dysmenorrhea
  4. 5.1.3 Premenstrual Syndrome (PMS)
  5. 5.1.4 Premenstrual Dysphoric Disorder (PMDD)
  6. 5.1.5 Birth Control
  7. 5.2 Global Drospirenone and Ethinylestradiol Tablets Sales by Application
  8. 5.2.1 Global Drospirenone and Ethinylestradiol Tablets Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Drospirenone and Ethinylestradiol Tablets Sales by Application (2021-2032)
  10. 5.2.3 Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2021-2032)
  11. 5.3 Global Drospirenone and Ethinylestradiol Tablets Revenue by Application
  12. 5.3.1 Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2021-2032)
  14. 5.3.3 Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application (2021-2032)
6 Global Drospirenone and Ethinylestradiol Tablets Sales by Region
  1. 6.1 Global Drospirenone and Ethinylestradiol Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drospirenone and Ethinylestradiol Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Drospirenone and Ethinylestradiol Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Drospirenone and Ethinylestradiol Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drospirenone and Ethinylestradiol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drospirenone and Ethinylestradiol Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drospirenone and Ethinylestradiol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drospirenone and Ethinylestradiol Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drospirenone and Ethinylestradiol Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region
  1. 7.1 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region
  2. 7.1.1 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Drospirenone and Ethinylestradiol Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drospirenone and Ethinylestradiol Tablets Revenue (2021-2032)
  8. 7.2.2 North America Drospirenone and Ethinylestradiol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drospirenone and Ethinylestradiol Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Drospirenone and Ethinylestradiol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drospirenone and Ethinylestradiol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drospirenone and Ethinylestradiol Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aurobindo Pharma
  2. 8.1.1 Aurobindo Pharma Company Information
  3. 8.1.2 Aurobindo Pharma Business Overview
  4. 8.1.3 Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Product Portfolio
  6. 8.1.5 Aurobindo Pharma Recent Developments
  7. 8.2 Barr Pharmaceuticals, Inc.
  8. 8.2.1 Barr Pharmaceuticals, Inc. Company Information
  9. 8.2.2 Barr Pharmaceuticals, Inc. Business Overview
  10. 8.2.3 Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Product Portfolio
  12. 8.2.5 Barr Pharmaceuticals, Inc. Recent Developments
  13. 8.3 Bayer Weimar GmbH und Co. KG
  14. 8.3.1 Bayer Weimar GmbH und Co. KG Company Information
  15. 8.3.2 Bayer Weimar GmbH und Co. KG Business Overview
  16. 8.3.3 Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Product Portfolio
  18. 8.3.5 Bayer Weimar GmbH und Co. KG Recent Developments
  19. 8.4 Camber Pharmaceuticals
  20. 8.4.1 Camber Pharmaceuticals Company Information
  21. 8.4.2 Camber Pharmaceuticals Business Overview
  22. 8.4.3 Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Portfolio
  24. 8.4.5 Camber Pharmaceuticals Recent Developments
  25. 8.5 Glenmark Pharmaceuticals
  26. 8.5.1 Glenmark Pharmaceuticals Company Information
  27. 8.5.2 Glenmark Pharmaceuticals Business Overview
  28. 8.5.3 Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Portfolio
  30. 8.5.5 Glenmark Pharmaceuticals Recent Developments
  31. 8.6 Hetero Drugs
  32. 8.6.1 Hetero Drugs Company Information
  33. 8.6.2 Hetero Drugs Business Overview
  34. 8.6.3 Hetero Drugs Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hetero Drugs Drospirenone and Ethinylestradiol Tablets Product Portfolio
  36. 8.6.5 Hetero Drugs Recent Developments
  37. 8.7 MYLAN LABS LTD.
  38. 8.7.1 MYLAN LABS LTD. Company Information
  39. 8.7.2 MYLAN LABS LTD. Business Overview
  40. 8.7.3 MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Product Portfolio
  42. 8.7.5 MYLAN LABS LTD. Recent Developments
  43. 8.8 Teva Generics
  44. 8.8.1 Teva Generics Company Information
  45. 8.8.2 Teva Generics Business Overview
  46. 8.8.3 Teva Generics Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Generics Drospirenone and Ethinylestradiol Tablets Product Portfolio
  48. 8.8.5 Teva Generics Recent Developments
  49. 8.9 Wellona Pharma
  50. 8.9.1 Wellona Pharma Company Information
  51. 8.9.2 Wellona Pharma Business Overview
  52. 8.9.3 Wellona Pharma Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wellona Pharma Drospirenone and Ethinylestradiol Tablets Product Portfolio
  54. 8.9.5 Wellona Pharma Recent Developments
  55. 8.10 Xiromed
  56. 8.10.1 Xiromed Company Information
  57. 8.10.2 Xiromed Business Overview
  58. 8.10.3 Xiromed Drospirenone and Ethinylestradiol Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Xiromed Drospirenone and Ethinylestradiol Tablets Product Portfolio
  60. 8.10.5 Xiromed Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drospirenone and Ethinylestradiol Tablets Value Chain Analysis
  2. 9.1.1 Drospirenone and Ethinylestradiol Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drospirenone and Ethinylestradiol Tablets Production Mode & Process
  6. 9.2 Drospirenone and Ethinylestradiol Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drospirenone and Ethinylestradiol Tablets Distributors
  9. 9.2.3 Drospirenone and Ethinylestradiol Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst